Jane Street’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.5K Buy
+2,610
New +$27.6K ﹤0.01% 11212
2025
Q1
– Sell
-507
Closed -$9.23K – 9592
2024
Q4
$9.23K Buy
+507
New +$10K ﹤0.01% 9185
2024
Q3
– Sell
-672
Closed -$9.45K – 9670
2024
Q2
$9.45K Sell
672
-1,661
-71% -$28.8K ﹤0.01% 9116
2024
Q1
$44.3K Buy
+2,333
New +$45.4K ﹤0.01% 8764
2023
Q2
– Sell
-3,124
Closed -$211K – 8799
2023
Q1
$211K Buy
+3,124
New +$188K ﹤0.01% 7770
2021
Q4
– Sell
-560
Closed -$91K – 10158
2021
Q3
$91K Sell
560
-850
-60% -$138K ﹤0.01% 9344
2021
Q2
$213K Buy
+1,410
New +$238K ﹤0.01% 8715
2020
Q4
– Sell
-785
Closed -$125K – 7546
2020
Q3
$125K Buy
+785
New +$142K ﹤0.01% 6677

Other funds holding CTSO

Jane Street's CTSO Position: Q2 2026 in Review

Jane Street opened a new position in Cytosorbents Corp (CTSO) in Q2 2026: 2,610 shares worth $19.5K. The stake represents ﹤0.01% of the portfolio and ranks #11212 among its holdings. This is a return to the name: Jane Street previously reported a position in CTSO as recently as Q4 2024.

Jane Street first reported a position in CTSO in Q3 2020 and has held it in 8 quarters since. The position peaked at $213K in Q2 2021. 47 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Jane Street held 2,610 shares of Cytosorbents Corp worth $19.5K as of Q2 2026.
  • Cytosorbents Corp was a new Jane Street position in Q2 2026.
  • Cytosorbents Corp made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11212 holding.
  • Jane Street first reported a position in Cytosorbents Corp in Q3 2020 and has held it in 8 quarters since.
  • Jane Street's Cytosorbents Corp position peaked at $213K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.